Supernus Pharmaceuticals
SUPN
#4375
Rank
โ‚น247.05 B
Marketcap
โ‚น4,257
Share price
-0.60%
Change (1 day)
49.19%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: โ‚น247.05 Billion

As of June 2026 Supernus Pharmaceuticals has a market cap of โ‚น247.05 Billion. This makes Supernus Pharmaceuticals the world's 4375th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น247.05 B-6.93%
2025โ‚น265.44 B50.72%
2024โ‚น176.12 B33.81%
2023โ‚น131.62 B-17.51%
2022โ‚น159.56 B38.24%
2021โ‚น115.42 B18.65%
2020โ‚น97.28 B9.48%
2019โ‚น88.85 B-26.88%
2018โ‚น121.52 B-6.83%
2017โ‚น130.43 B53.45%
2016โ‚น85.00 B94.21%
2015โ‚น43.76 B93.61%
2014โ‚น22.60 B21.37%
2013โ‚น18.62 B54.93%
2012โ‚น12.02 B

End of Day market cap according to different sources

On Jun 8th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

โ‚น247.05 Billion
by Nasdaq info icon info icon
โ‚น247.05 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.481 T 21,547.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น15.085 T 6,006.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น98.066 T 39,594.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น10.859 T 4,295.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚น143.56 B-41.89%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚น2.212 T 795.58%๐Ÿ‡บ๐Ÿ‡ธ USA